A Pediatric Phase 1 Trial and Pharmacokinetic Study of Ispinesib: A Children's Oncology Group Phase I Consortium Study

af Souid, Abdul-Kader, Dubowy, Ronald L., Ingle, Ashish M., Conlan, Maureen G., Sun, Junfeng, Blaney, Susan M., Adamson, Peter C.
Udgivet 2010

SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis

af Mesa, Ruben A., Kiladjian, Jean-Jacques, Catalano, John V., Devos, Timothy, Egyed, Miklos, Hellmann, Andrzei, McLornan, Donal, Shimoda, Kazuya, Winton, Elliott F., Deng, Wei, Dubowy, Ronald L., Maltzman, Julia D., Cervantes, Francisco, Gotlib, Jason
Udgivet i J Clin Oncol (2017)

The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab

af Kreuzer, Karl-Anton, Furman, Richard R., Stilgenbauer, Stephan, Dubowy, Ronald L., Kim, Yeonhee, Munugalavadla, Veerendra, Lilienweiss, Esther, Reinhardt, Hans Christian, Cramer, Paula, Eichhorst, Barbara, Hillmen, Peter, O’Brien, Susan M., Pettitt, Andrew R., Hallek, Michael
Udgivet i Leukemia (2019)

A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia

af O'Brien, Susan M., Lamanna, Nicole, Kipps, Thomas J., Flinn, Ian, Zelenetz, Andrew D., Burger, Jan A., Keating, Michael, Mitra, Siddhartha, Holes, Leanne, Yu, Albert S., Johnson, David M., Miller, Langdon L., Kim, Yeonhee, Dansey, Roger D., Dubowy, Ronald L., Coutre, Steven E.
Udgivet i Blood (2015)